Our Pricing

Understanding the Wegovy Price Increase: What UK Patients Need to Know in 2025

The recent wegovy price increase has prompted many UK patients to seek clearer information about current costs and availability across all doses. Following supply stabilisation and manufacturer pricing adjustments in early 2025, Wegovy (semaglutide) injections are now available at Cured Pharmacy from £69.00 for all dose strengths, representing competitive UK pricing with transparent upfront costs. This guide explains the price changes, what they mean for your weight loss journey, and how to access genuine Wegovy at the most affordable rates.

What Caused the Wegovy Price Increase in the UK?

The wegovy price increase observed across UK pharmacies in 2025 stems from multiple factors including manufacturing capacity adjustments, supply chain normalisation, and revised wholesale pricing from Novo Nordisk [1]. After significant shortages throughout 2023-2024, production has stabilised, but wholesale costs have been adjusted to reflect sustained demand and distribution infrastructure improvements.

Regulatory changes and increased quality assurance requirements from the MHRA have also contributed to cost adjustments across GLP-1 medications [2]. At Cured Pharmacy, we've absorbed some of these increases to maintain the most competitive pricing structure in the UK market, offering all Wegovy doses from £69.00 with our transparent pricing model that shows costs before you complete your clinical assessment.

Current Wegovy Price Increase: All Doses Available from £89.00

Following the wegovy price increase, Cured Pharmacy maintains the lowest UK pricing across all maintenance doses. Our pricing structure reflects genuine wholesale costs plus a minimal dispensing fee, with no hidden charges or subscription lock-ins that inflate long-term treatment costs.

Every Wegovy prescription at Cured Pharmacy includes a free online consultation with a UK-registered prescriber, completed in under 3 minutes, with prescriptions issued the same day subject to clinical suitability. Your medication ships via next-day tracked delivery in 100% discreet packaging, with no additional delivery charges added at checkout.

Wegovy Dose Pricing After the Price Increase

All Wegovy injection pens (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg maintenance dose) are priced identically at £69.00 per 4-week supply at Cured Pharmacy. This unified pricing structure simplifies budgeting throughout your dose escalation schedule, eliminating the confusion of variable costs as you progress from starter to maintenance doses [3].

New patients can save an additional £20 off their first order using code Weightlossnew, bringing the initial month's cost to £69.00. This discount applies automatically at checkout when you complete your clinical assessment through our secure online platform.

How Does the Wegovy Price Increase Compare to Other Weight Loss Treatments?

Despite the wegovy price increase, semaglutide injections remain competitively priced against alternative prescription weight loss medications when evaluated on a cost-per-kilogram-lost basis. Clinical trial data from the STEP programme showed average weight loss of 15% body weight over 68 weeks with Wegovy 2.4mg, compared to 2.4% with placebo [4].

When comparing monthly treatment costs, Wegovy's efficacy profile often justifies the investment for patients who haven't achieved results with lower-cost options like orlistat. At Cured Pharmacy, we offer the full spectrum of MHRA-licensed weight loss treatments, allowing our prescribers to recommend the most clinically appropriate and cost-effective option based on your individual circumstances, BMI, and medical history.

Wegovy vs Mounjaro: Price and Efficacy After Recent Increases

Mounjaro (tirzepatide) represents the newest GLP-1/GIP dual agonist, with clinical trials demonstrating average weight loss of 20.9% body weight at the 15mg maintenance dose [5]. At Cured Pharmacy, Mounjaro starts from £69.00 per 4-week supply, positioning it at a higher price point than Wegovy following the recent price adjustments.

For many patients, Wegovy at £20 offers an excellent balance of proven efficacy and affordability, particularly for those new to GLP-1 medications. Our clinical team can guide you through the comparative benefits during your online consultation, ensuring you select the treatment that aligns with both your clinical needs and budget considerations.

Managing Wegovy Price Increase: Cost-Saving Strategies for UK Patients

The wegovy price increase needn't derail your weight loss journey if you approach treatment costs strategically. At Cured Pharmacy, we recommend several approaches to optimise affordability: using our first-order discount code Weightlossnew for £20 off, planning purchases to align with promotional periods, and discussing treatment duration expectations with your prescriber to set realistic budgeting timelines.

Transparent pricing before consultation distinguishes Cured Pharmacy from subscription-model providers that lock patients into long-term contracts with escalating costs. You pay £69.00 per month with no membership fees, cancellation charges, or price increases after sign-up, giving you complete control over your treatment expenses and the flexibility to pause or adjust as your clinical needs evolve.

Is Wegovy Still Worth It After the Price Increase?

Evaluating whether Wegovy justifies its cost after the wegovy price increase requires considering both clinical outcomes and long-term health economics. Peer-reviewed research demonstrates that semaglutide 2.4mg produces sustained weight loss that translates to measurable improvements in cardiovascular risk markers, HbA1c levels in patients with type 2 diabetes, and quality of life metrics [6].

For patients with a BMI over 30 (or over 27 with weight-related comorbidities), the £69.00 monthly investment at Cured Pharmacy represents approximately £69.00 per day for a medication that addresses the underlying biological mechanisms of weight regulation, rather than relying solely on behavioural modification. When compared to the cumulative costs of obesity-related health complications, many patients and clinicians view GLP-1 therapy as cost-effective preventive medicine [7].

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) regularly counsels patients on treatment value: 'The wegovy price increase reflects global supply dynamics, but at £69.00 per month, UK patients at Cured Pharmacy still access one of the most evidence-based weight loss interventions available, with clinical trial data showing average losses of 15% body weight maintained over multiple years when combined with lifestyle modifications.'

Long-Term Cost Considerations for Wegovy Treatment

Most patients require 12-18 months of Wegovy treatment to achieve and stabilise their target weight loss, with some continuing maintenance therapy longer-term to prevent weight regain [8]. At £69.00 per month, a 12-month course totals £69.00 or £69.00 when factoring in the £69.00 first-order discount available at Cured Pharmacy.

This total cost should be weighed against the documented health benefits: clinical trials show Wegovy reduces the risk of major adverse cardiovascular events by 20% in patients with established cardiovascular disease, alongside improvements in sleep apnoea, joint pain, and metabolic markers that reduce long-term healthcare costs and improve quality of life.

How to Order Wegovy at the Lowest UK Price After the Price Increase

Accessing Wegovy at £69.00 following the wegovy price increase requires completing a clinical assessment with a UK-registered prescriber, as semaglutide is a prescription-only medication regulated by the MHRA. At Cured Pharmacy, this process takes under 3 minutes through our secure online platform, with prescriptions reviewed and issued the same day for clinically suitable patients.

Our streamlined ordering process begins with a brief medical questionnaire covering your weight history, current medications, and relevant health conditions. A UK prescriber reviews your submission within hours, and upon approval, your Wegovy ships via next-day tracked courier in discreet packaging with no external branding. You'll receive SMS tracking updates and can contact our pharmacist team on (+44) 116 4646009 with any questions about administration, side effects, or dose progression.

First-time patients should apply discount code Weightlossnew at checkout to reduce the initial month's cost to £69.00. Repeat prescriptions can be requested through your online account dashboard, with automatic reminders sent before your current supply runs out to ensure uninterrupted treatment continuity throughout your weight loss journey.

Scientific References

1. Novo Nordisk. (2024). Supply update: Wegovy (semaglutide) injection availability and pricing. Novo Nordisk Investor Relations. [accessed 15 August 2026]
2. Medicines and Healthcare products Regulatory Agency. (2024). GLP-1 receptor agonists: Regulatory guidance and quality standards. MHRA Guidance. [accessed 15 August 2026]
3. Wilding, J.P.H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
4. Rubino, D., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
5. Jastreboff, A.M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
6. Davies, M., et al. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): A randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet, 397(10278), 971-984. [accessed 15 August 2026]
7. Garvey, W.T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: The STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
8. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity: Technology appraisal guidance. NICE TA875. [accessed 15 August 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.